SCHEMBL5847529

SCHEMBL5847529

OC1(c2ccccc2)CCN(CCCCn2ccc3ccccc32)CC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.58
P2RX7 Q99572 1/20 0.57
CDK4 P11802 3/20 0.56
CCND1 P24385 3/20 0.56
DRD2 P14416 3/20 0.55
DRD4 P21917 1/20 0.55
DRD3 P35462 1/20 0.55
ABCB1 P08183 1/20 0.53
OPRL1 P41146 2/20 0.51
CCR3 P51677 1/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.51
SLC6A1 P30531 1/20 0.49
SLC6A12 P48065 1/20 0.49
SLC6A11 P48066 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298382 0.81 DRD2 (0.63) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL3990196 0.79 CDK4 (0.73) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL9776119 0.78 CDK4 (0.74) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL5847565 0.78 DRD2 (0.59) SIGMAR1P2RX7DRD2DRD4DRD3
SCHEMBL30298377 0.78 DRD2 (0.59) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL5847154 0.78 P2RX7 (0.59) SIGMAR1P2RX7DRD2OPRL1CCR3
SCHEMBL9776034 0.76 CDK4 (0.72) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL3989584 0.76 CDK4 (0.73) SIGMAR1P2RX7CDK4CCND1DRD2
SCHEMBL9370237 0.76 SIGMAR1 (0.72) SIGMAR1DRD2OPRL1CCR3MEN1
SCHEMBL15578543 0.75 CDK4 (0.67) SIGMAR1P2RX7CDK4CCND1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39113-E1 Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-05-30 US claimed
EP-0721455-B9 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2005-04-20 EP claimed
CN-1120167-C Tetrahydropyridine-(or 4-hydroxypiperidine) Alkylazoles having an affinity for sigma and/or 5HTIA receptors ESTEVE S A LAB DE DR (ES) 2003-09-03 CN claimed
EP-1097698-B1 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN ESTEVE LABOR DR (ES) 2003-05-07 EP claimed
EP-0721455-B1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2002-12-11 EP claimed
EP-1097698-A2 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-05-09 EP claimed
CN-1166173-A Tetrahydropyridine- (or 4-hydroxypiperidine) alkylpyrroles active at sigma and/or 5HTIA receptors ESTEVE S A LAB DE DR (ES) 1997-11-26 CN claimed